IT-141 - Intezyne
Padcev (enfortumab vedotin) - Seagen, Astellas
Trodelvy (sacituzumab govitecan-hziy) - Everest Medicines, Gilead
Balversa (erdafitinib) - J&J
Keytruda (pembrolizumab) - Merck (MSD)
https://www.targetedonc.com/view/novel-sequencing-strategies-for-advanced-urothelial-carcinoma
 
Aug 30, 2021
 
Next